The use of botulinum toxin for the treatment of temporomandibular disorders: Preliminary findings

Journal of Oral and Maxillofacial Surgery

Volumn 57, Issue 8, 1999, Pages 916-920

  Freund, Brian ^a,b   Schwartz, Marvin ^a   Symington, John M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; EMLA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ELECTROMYOGRAPHY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT CHARACTERISTICS AND FUNCTIONS; MALE; MASSETER MUSCLE; MASTICATION; TEMPORALIS MUSCLE; TEMPOROMANDIBULAR JOINT DISORDER; TREATMENT OUTCOME;

EID: 0032795289     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2391(99)90007-1     Document Type: Article

References (28)

1. Dworkin SF: Behavioral characteristics of chronic temporomandibular disorders: Diagnosis and treatment, in Sessle BJ, Bryant PS, Dionne RA (eds): Progress in Pain Research and Management, vol 4. Seattle, WA, IASP Press, 1995, pp 175-192
2. Carlsson GE: Epidemiological studies of signs and symptoms of temporomandibular-joint-pain-dysfunction: A literature review. Aust Prosthodont Soc Bull 14:7, 1984
3. DeLeeuw R, Boering G, Stegenga B, et al: Clinical signs of TMJ osteoarthrosis and internal derangement 30 years after non-surgical treatment. J Orofacial Pain 8:18-24, 1994
4. Fricton J, Kroening R, Haley D, et al: Myofascial pain and dysfunction of the head and neck: A review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol 57:615, 1985
5. Bales JM, Epstein JB: The role of malocclusion and orthodontics in temporomandibular disorders. J Can Dent Assoc 60:899, 1994
6. Freund BJ, Schwartz M: The Use of Botulinum Toxin for the Treatment of Temporomandibular Disorder. Oral Health 88:32-37, 1998
7. Dworkin SF, LeResche L: Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 6:301, 1992
8. Blanksana NG, van Eijden TM: EMG heterogeneity in human tetnporalis and masseter muscle during static biting, open/close excursions and chewing. J Dental Res 74:1318-1327, 1995
9. Paphangkorakit J, Osborn JW: Effect of jaw opening on the direction and magnitude of human incisai bite forces. J Dent Res 76:561, 1997
10. Scott AB, Rosenbaum A, Collins CC: Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12:924, 1973
11. Scott AB: Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044, 1980
12. Jankovic J: Blepharospasm with basal ganglia lesions. Arch Neurol 43:866, 1986
13. Magoon EH: Chemodernervation of strabismic children: A 2 to 5 year follow-up study compared with shorter follow-up. Ophthalmology 96:931, 1989
14. Jankovic J, Fahn S: Dystonic syndromes, in Jankovic J, Tolosa E (eds): Parkinson's Disease and Movement Disorders. Baltimore. MD, Urban & Schwarzenberg, 1988, pp 283-314
15. Jankovic J, Orman J: Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study. Neurology 37:616, 1987
16. Blitzer A, Brin MF, Green PE, et al: Botulinum toxin injection for the treatment of oromandibular dystonia, in Transactions of the American Laryngological Association, San Francisco, Vol 110, April 1-2, 1989. St Louis, MO, American Laryngological Association, 1989 (abstr 206)
17. Blitzer A, Brin MF, Greene PE, et al: Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 98:93, 1989
18. Jankovic J, Schwartz K, Donovan DT: Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 53:633, 1990
19. Cheshire WP, Abashian SW, Mann JD: Botulinum toxin in the treatment of myofascial pain syndrome. Pain 59:65, 1994
20. Jankovic J, Schwartz K: Botulinum toxin injections for cervical dystonia. Neurology 40:277, 1990
21. Dutton JJ: Botulinum-A toxin in the treatment of craniocervical muscle spasms: Short- and long-term, local and systemic effects. Surv Ophthalmol 41:51, 1996
22. Shaari CM, Sanders I: Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 16:964, 1993
23. Filippi GM, Errico P, Santarelli R, et al: Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 113:400, 1993
24. Lund JP, Donga R, Widmer CG: The pain adaptation model: A discussion of the relationship between chronic musculosket etal pain and motor activity. Can J Physiol Pharmacol 69:683, 1991
25. Gramling SE, Grayson RL, Sullivan TN, et al: Schedule-induced masseter EMG in facial pain subjects vs no-pain controls. Physiol Behav 61:301, 1997
26. Holds JB, Alderson K, Fogg SG, et al: Motor nerve sprouting in human orbicularis muscle following botulinum toxin A injection. Invest Ophthalmol Vis Res 31:964, 1990
27. Mense S: Nociception from skeletal muscle in relation to clinical muscle pain. Pain 54:241, 1993
28. Sessle BJ: Biological & psychological aspects of orofacial pain, in Stohler CS, Carlson DS (eds): Craniofacial Growth Series 29, Center for Human Growth & Development, Ann Arbor, MI, The University of Michigan, 1994